Implications for cost-effectiveness. Combination therapy for systemic hypertension.
Kaplan
N M
NM
D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000191:economics; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000191:economics; D012307:Risk Factors
D000959:Antihypertensive Agents